Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma

Motzer, Robert J.; Barrios, Carlos H.; Min Kim, Tae; Falcon, Silvia; Cosgriff, Thomas; Graydon Harker, W.; Srimuninnimit, Vichien; Pittman, Ken; Sabbatini, Roberto; Young Rha, Sun; Flaig, Thomas W.; Page, Ray; Bavbek, Sevil; Thaddeus Beck, J.; Patel, Poulam; Cheung, Foon-yiu; Yadav, Sunil; Schiff, Edward M.; Wang, Xufang; Niolat, Julie; Sellami, Dalila; Anak, Oezlem; Knox, Jennifer J.

Robert J. Motzer

Carlos H. Barrios

Tae Min Kim

Silvia Falcon

Thomas Cosgriff

W. Graydon Harker

Vichien Srimuninnimit

Ken Pittman

Roberto Sabbatini

Sun Young Rha

Thomas W. Flaig

Ray Page

Sevil Bavbek

J. Thaddeus Beck

POULAM PATEL POULAM.PATEL@NOTTINGHAM.AC.UK
Professor of Clinical Oncology

Foon-yiu Cheung

Sunil Yadav

Edward M. Schiff

Xufang Wang

Julie Niolat

Dalila Sellami

Oezlem Anak

Jennifer J. Knox

Journal Article Type	Article
Online Publication Date	Jul 21, 2014
Publication Date	Sep 1, 2014
Deposit Date	Jul 5, 2018
Print ISSN	0732-183X
Electronic ISSN	1527-7755
Publisher	American Society of Clinical Oncology
Peer Reviewed	Peer Reviewed
Volume	32
Issue	25
Pages	2765-2772
DOI	https://doi.org/10.1200/JCO.2013.54.6911
Public URL	https://nottingham-repository.worktribe.com/output/1117578
Publisher URL	https://ascopubs.org/doi/10.1200/JCO.2013.54.6911
PMID	25049330